The results of this study showed milnacipran 150 mg/day and 100 mg/day to be efficacious and well tolerated in the long-term treatment of major depression in an outpatient setting. In randomised ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback